Health Care & Life Sciences » Biotechnology | 22nd Century Group Inc.

22nd Century Group Inc.

22nd Century Group Inc.
Stock Exchange NYSE
EPS
$0.09
Market Cap
$243.09 M
Shares Outstanding
124.66 M
Public Float
113.33 M
22nd Century Group Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
124.37 M
Public Float
115.25 M

Profile

Address
8560 Main Street
Clarence New York 14221
United States
Employees -
Website http://www.xxiicentury.com
Updated 07/08/2019
22nd Century Group, Inc. is a plant biotechnology company, which engages in the development of technology that will allow to increase or decrease the level of nicotine and nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes, and verfola. The company was founded on January 25, 2011 and is headquartered in Clarence, NY.

Financials

View All

Henry Sicignano
President, Chief Executive Officer & Director
James W. Cornell
Chairman